Other OTC Pharmaceuticals (Pharmacies) - Spain

  • Spain
  • Revenue in the Other OTC Pharmaceuticals market is projected to reach US$0.40bn in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.98%, resulting in a market volume of US$0.42bn by 2029.
  • In global comparison, most revenue will be generated in the United States (US$4,981.00m in 2024).
  • In relation to total population figures, per person revenues of US$8.36 are generated in 2024.

Key regions: France, Australia, India, South Korea, Germany

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals (Pharmacies) market in Spain is experiencing steady growth due to various factors. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors all contribute to the development of the market.

Customer preferences:
In Spain, customers have a strong preference for over-the-counter (OTC) pharmaceutical products. This is driven by several factors, including convenience, accessibility, and cost-effectiveness. Many consumers prefer to self-medicate for minor ailments and rely on OTC products available at pharmacies. The ease of access to these products without a prescription is highly valued by customers.

Trends in the market:
One notable trend in the Other OTC Pharmaceuticals (Pharmacies) market in Spain is the increasing demand for natural and herbal remedies. Consumers are becoming more health-conscious and are seeking alternative options to traditional pharmaceutical products. This trend is driven by a growing interest in holistic health and wellness. As a result, pharmacies in Spain are expanding their range of natural and herbal OTC products to meet the demand. Another trend in the market is the rise of online pharmacies. With the increasing popularity of e-commerce, more consumers are turning to online platforms to purchase OTC pharmaceutical products. Online pharmacies offer convenience and competitive pricing, attracting a significant customer base. This trend has led to increased competition among traditional brick-and-mortar pharmacies, prompting them to improve their online presence and offer additional services to stay competitive.

Local special circumstances:
Spain has a well-established healthcare system, which includes a network of pharmacies that play a crucial role in providing healthcare services to the population. Pharmacies in Spain are highly regulated and are required to have a licensed pharmacist on-site at all times. This ensures the quality and safety of OTC pharmaceutical products and provides customers with professional advice and guidance.

Underlying macroeconomic factors:
The growth of the Other OTC Pharmaceuticals (Pharmacies) market in Spain is also influenced by underlying macroeconomic factors. Spain has a stable economy and a growing population, which contributes to increased consumer spending on healthcare products. Additionally, the country has a high life expectancy and an aging population, leading to a higher demand for OTC pharmaceutical products to manage age-related health issues. In conclusion, the Other OTC Pharmaceuticals (Pharmacies) market in Spain is developing due to customer preferences for convenience and accessibility, trends such as the demand for natural and herbal remedies, the rise of online pharmacies, local special circumstances including a well-regulated healthcare system, and underlying macroeconomic factors such as a stable economy and an aging population. These factors collectively contribute to the steady growth of the market in Spain.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)